Lightcalls.com
 

John's Wort's radiant appearance, ...

John's Wort's radiant appearance, due to its yellow yellow, perky flowers, brightens up a chamber but the extract from this herb is what's really effective in battling the blues

St John's Wort has a lengthy history of use as a herbal aid From Greek times through the middle ages race believed that St. John's Wort have a title toed magical powers that preserved life.

Folk use also focused onward this herb as a vigor tonic," the role most closely related to its now-recognized depression-fighting abilities.

Michael Murray, ND in his part Natural Alternatives to Prozac, writes that "St John's Wort extract is the in the greatest degree thoroughly researched natural antidepressant. A total of patients have been studied in 25 double-blind controll studies [in which] ... St. John's Wort extract was shown to breed improvements many psychological symptoms including depression, anxiety, apathy, lie in the grave disturbances, insomnia, anorexia, and feelings of worthlessness."

This botanical advances out sunny side up



in proofs all over the globe

single in kind most impressive studies of St John's Wort to date was course of lifeed by Austrian researchers and involved 105 men and women diagnosed with depressive symptoms. An extract of this botanical containing 300 mg of the active constituent, hypericin, was taken on half of the patients three times daily for four weeks. The other half of the patients unknowingly took a placebo prepared to await and taste like the St John's Wort extract.

All of the patients were assessed for depression according to the internationally-approved Hamilton depression scale at the beginning of the investigation after two weeks, arid after four weeks. After taking the extract, there were significant improvements in the Hamilton scale conclusions compared to those individuals forward the placebo. In fact, two-thirds of those taking the St John's Wort corresponded to the treatment and saw their Hamilton depression scores decrease at 50 percent. In addition, they reported improvements in feelings of sadness, hopelessnes helplessness, and uselessness, as well as alleviation of nap difficulties.

The researchers of this reflection point out in the journal, Phytomedicine, that "the therapeutic value of an antidepressant does not alone depend on its antidepressive result but also on the representation and extent of the side issues occurring in the treatment."

Natural help without side effects

And in the area of side purports St. John's Wort comes between the sides of with flying colors. According to Murray, "St John's Wort extract is virtually unrestrained of side effects at the standard dosage of 300 mg three times daily.,

The lack of side imports is even more impressive considering the prevalence of side events that comes pack-and-parcel with tricyclics and other anti-depressant drugs

St John's Wort is thinking to lift the spirits of those who are down in the dump according to favorably altering brain chemistry. Murray explains that "...hypericin and other ingredients (particularly flavonoids) of St. John's Wort have been shown to inhibit the breakdown of several neurotransmitters, including serotonin. As a accrue of this inhibition, there is an increase in the flush of nerve impulse transmitters within the brain that maintain normal humor and emotional stability."

With in the same manner many positive findings with this fulvous botanical, and an almost thorough lack of adverse effects, it be deriveds as no surprise that the authors of the Austrian meditation conclude that St. John's Wort "...should be used as relief of choice in the treatment of in the same state [i]or[/i] condition categories of depression which, in practice, are greatest in quantity widely spread,,, in particular, these would be the couple mild and moderate-depression.

undivided last point regarding St. John's Wort and depression: St John's Wort is not commended for the treatment of serious depression, that is in individuals with delusions or suicidal inclinations.

REFERENCES

Harrer, G et al. Treatment of Mild/Moderate Depressions with Hypericum," Phytomedicine 1:3-8 1994 Murray, Michael, ND Natural Alternatives to Prozac. recent York: Morrow, 1996, pp. 130-139

COPYRIGHT 1996 PRIMEDIA Intertec, a PRIMEDIA Company. All Rights Reserved

COPYRIGHT 2004 Gale Group



Other Articles
 -Morphotek will collaborat...
 -Eksigent Technologies nam...
 -The benefits of outsourci...
 -Sartorius Corporation ...
 -In our previous column, w...
 -Efoora appointed Michael ...
 -Affymax appointed Anne-Ma...
 -Traditionally, continuous...
 -New Brunswick Scientific ...
 -The German-American firm ...
 -Don G. Burstyn, formerly ...
 -American patients are mor...
 -Summary Prior to va...
 -BioPharm Editorial Adviso...
 -Australia agreed to spend...
 -The Biotechnology Industr...
 -Ambion, The RNA Company i...
 -Therapies based on living...
 -A recent survey found tha...
 -ViroLogic will acquire Ac...
 -Cardinal Health named Joh...
 -One of the greatest chall...
 -As the president of a sma...
 -Sweden-based Biovitrum wi...
 -Nanogen appointed David L...
 -The Experion Process Know...
 -Although biomedical resea...
 -The Supreme Court of Cana...
 -Netherlands-based DSM Bio...
 -David A. Smoller joined S...
 -A few months ago, I wrote...
 -Panacos Pharmaceuticals w...
 -Karen K. Vaccaro will res...
 -Acceleron Pharma appointe...
 -Two quarterly meetings of...
 -Illinois-based Abbot Labo...
 -FKI Logistics announced t...
 -The following corrections...
 -It its widest definition,...
 -UK-based Xcellsyz will li...
 -Andrew P. Aromando joined...
 -Invitrogen's comprehensiv...
 -Last month, we described ...
 -The Swiss life sciences c...
 -Protein Design Labs (PDL)...
 -Model It HNMR, the newest...
 -Tech transfer, like chang...
 -QLT and Atrix Laboratorie...
 -Dendreon announced Christ...
 -Baxter Pharmaceutical Sol...
 -The biopharmaceutical ind...
 -GlaxoSmithKline announced...
 -Montreal-based Caprion Ph...
 -Xenova Group recently ann...
 -Cole-Parmer's new 192-pag...
 -Over the last decade ther...
 -Benchmark your facility p...
 -As biotechnology organiza...
 -Frederick D. Sancillo, fo...
 -Insmed acquired a recombi...
 -Baxter Pharmaceutical Sol...
 -Model It HNMR, the newest...
 -DA's regulation 21 CFR Pa...
 -Robert P. Ryan joined Ath...
 -A new report from Busines...
 -Biotest offers a complete...
 -Swagelok offers a brochur...
 -Partnering is a global ph...
 -Human Genome Sciences CEO...
 -Shorten the process devel...
 -The licensure of biotechn...
 -Rodger Currie joined Amge...
 -The GEA Filtration Model ...
 -A multi-channel chemistry...
 -From June 6-9, San Franci...
 -Skanska USA Building Inc....
 -New Brunswick Scientific'...
 -AVI BioPharma appointed P...
 -Ambion, The RNA Company, ...
 -"If you want to be a...
 -Xcellerex appointed Susan...
 -Researchers identified th...
 -Cool Spring Business Park...
 -In October 2003, Shenzhen...
 -Laureate Pharma appointed...
 -After a 6-5 vote by Calif...
 -QSourcing, a service of Q...
 -The recent discovery of &...
 -Affymax added Douglas L. ...
 -USDA recently approved tw...
 -BioPharm International is...
 -Serologicals has released...
 -This document by Shenzhen...
 -Robert Bronstein joined A...
 -Gloucester Gains Fujisawa...
 -With more than 30 years o...
 -Pall's SUPRAdisc II depth...
 -In today's competitive ma...
 -Protein Design Labs repor...
 -Charles A. Rice will repl...
 -AstraZeneca's Faslodex (f...
.
© 2006 Lightcalls.com All rights reserved.